Showing results (51-60 of 163) with videos related to
Sort By:
Pageof 17
Blood|July 15, 1994
Inhibition of heparin activity in plasma by soluble fibrin: evidence for ternary thrombin-fibrin-heparin complex formationK A Hotchkiss, C N Chesterman, P J HoggBiochemistry|May 31, 1994
Identification of possible inhibitory reactive centers in thrombospondin 1 that may bind cathepsin G and neutrophil elastaseP J Hogg, B M Jiménez, C N ChestermanAdvances in Immunology|January 1, 1991
Immunology and clinical importance of antiphospholipid antibodiesH P McNeil, C N Chesterman, S A KrilisThrombosis Research|December 15, 1988
Binding specificity of lupus anticoagulants and anticardiolipin antibodiesH P McNeil, C N Chesterman, S A KrilisJournal of Cellular Biochemistry|March 20, 2001
Early growth response factor-1 mediates insulin-inducible vascular endothelial cell proliferation and regrowth after injuryN Gousseva, K Kugathasan, C N Chesterman, et al.Thrombosis and Haemostasis|January 31, 2002
Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome studyB H Chong, A S Gallus, J F Cade, et al.Journal of Cellular Physiology|May 1, 1996
Fibroblast growth factor and heparin protect endothelial cells from the effects of interleukin 1A J Minter, E Keoshkerian, C N Chesterman, et al.Australian and New Zealand Journal of Medicine|April 1, 1993
Clinical analysis of 125 patients with the lupus anticoagulantM Morgan, K Downs, C N Chesterman, et al.FEBS Letters|October 3, 1983
Phosphorylation sites for ribosomal S6 protein kinases in mouse 3T3 fibroblasts stimulated with platelet-derived growth factorR E Wettenhall, C N Chesterman, T Walker, et al.Anticancer Research|March 1, 1995
Platelet-derived growth factor A-chain synthetic peptide inhibits human glioma xenograft proliferation in nude miceL M Khachigian, S L Field, R Crouch, et al.Pageof 17